SMG
Scotts Miracle-Gro Co Materials Agricultural Chemicals Russell 3000
$62.24Close
$3.6BMarket cap
$48.44 – $72.6852-week range
Nov 4, 2026Next report · before the open
Highlights
Cautions
- Not in an uptrend 3 of 8 trend conditions
- Lagging the market RS 46 · weaker than 54% of stocks over 12 months
- Extended 4.3 ATR above its 50-day average
- Earnings shrinking EPS −26% year on year
- Results soon Nov 4, 2026, in 3 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
14%
1wk
up 5.0%
price change
1mo
up 24.2%
price change
12-month return
up 22%
market up 11% ·
its own up 10%
F-score
6 / 9
Mixed
Altman Z
2.61
Moderate risk
P/E
24.8×
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
up 6.4%
EBIT / enterprise value
Cheaper than
79%
of the market · cheap
Revenue growth
down 4%
year on year
EPS growth
down 26%
latest quarter · -34 pts
Sales growth
up 1%
latest quarter · -4 pts
ROE
—
return on equity
Free cash margin
up 8%
$273.9M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
5.6×
Interest cover
2.8×EBIT / interest
Piotroski tests
- took on more long-term debt
- short-term liquidity weakened
- issued more shares
- profitable on its assets
- generating cash from operations
- profitability improving
- profits backed by cash
- gross margin widened
- assets working harder
Repair signals
- Long-term debt down 6% ($2.2B → $2.0B)
- Gross margin 23.9% → 30.6%
Trade setup
ATR%
2.9%
$1.82 a day · 2×ATR $58.61
RS
46 / 99
vs the universe
Trend
3 / 8
trend template
Relative volume
1.5×
vs 50-day average
Up/down volume
1.05
50 sessions
Implied move
—
no option chain · report Nov 4, 2026
Trend template · 3 of 8
- Price above the 150 and 200-day averages: passes
- 150-day average above the 200-day: fails
- 200-day average rising for a month: fails
- 50-day average above the 150 and 200-day: fails
- Price above the 50-day average: passes
- At least 30% above the 52-week low: fails
- Within 25% of the 52-week high: passes
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Liabilities exceed assets Shareholders' equity is negative at -$357.5M as of Sep 30, 2025. What is left for shareholders after creditors is, on the balance sheet, less than nothing.
- Heavily indebted Net debt is 5.6 times EBITDA — roughly 6 years of earnings before interest, tax and depreciation to repay borrowings in full.
- Revenue shrinking Revenue fell 3.9% over the year, from $3.6B to $3.4B.
Last reported
Jul 29, 2026
Financials
- Gross 31%
- Net 4%
- Free cash 8%
- Cash
- Long-term debt
| FY2020Sep 30, 2020 | FY2021Sep 30, 2021 | FY2022Sep 30, 2022 | FY2023Sep 30, 2023 | FY2024Sep 30, 2024 | FY2025Sep 30, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $4.1B | $4.9B | $3.9B | $3.6B | $3.6B | $3.4B |
| Gross margin | 33% | 30% | 22% | 19% | 24% | 31% |
| Operating income | $585.2M | $723.0M | -$434.0M | -$174.4M | $208.8M | $358.6M |
| Net income | $387.4M | $512.5M | -$437.5M | -$380.1M | -$34.9M | $145.2M |
| Net margin | 9% | 10% | -11% | -11% | -1% | 4% |
| Earnings per share | $6.81 | $8.96 | -$7.88 | -$6.79 | -$0.61 | $2.47 |
| Free cash flow | $495.3M | $164.6M | -$242.5M | $438.2M | $583.5M | $273.9M |
| Free cash margin | 12% | 3% | -6% | 12% | 16% | 8% |
| Cash | $16.6M | $244.1M | $86.8M | $31.9M | $71.6M | $32.8M |
| Long-term debt | $1.5B | $2.2B | $2.8B | $2.6B | $2.2B | $2.0B |
| Shareholders' equity | $697.2M | $1.0B | $147.7M | -$267.3M | -$390.6M | -$357.5M |
| Shares outstanding | 55.80m | 55.60m | 55.50m | 56.50m | 57.10m | 57.80m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 5, 2026 | Quarterly ↗ | Jun 27, 2026 | 39d |
| May 6, 2026 | Quarterly ↗ | Mar 28, 2026 | 39d |
| Feb 4, 2026 | Quarterly ↗ | Dec 27, 2025 | 39d |
| Nov 25, 2025 | Annual ↗ | Sep 30, 2025 | 56d |
| Aug 6, 2025 | Quarterly ↗ | Jun 28, 2025 | 39d |
| May 7, 2025 | Quarterly ↗ | Mar 29, 2025 | 39d |
| Feb 5, 2025 | Quarterly ↗ | Dec 28, 2024 | 39d |
| Nov 26, 2024 | Annual ↗ | Sep 30, 2024 | 57d |
| Aug 7, 2024 | Quarterly ↗ | Jun 29, 2024 | 39d |
| May 8, 2024 | Quarterly ↗ | Mar 30, 2024 | 39d |
| Feb 7, 2024 | Quarterly ↗ | Dec 30, 2023 | 39d |
| Nov 22, 2023 | Annual ↗ | Sep 30, 2023 | 53d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 16, 2026 | Director or officer change ↗ |
| Sep 15, 2026 | Agreement ended · Other events ↗ |
| Sep 11, 2026 | Director or officer change ↗ |
| Sep 3, 2026 | Director or officer change ↗ |
| Aug 27, 2026 | Material agreement ↗ |
| Jul 29, 2026 | Results ↗ |
| Jul 1, 2026 | Director or officer change ↗ |
| Apr 29, 2026 | Results · Regulation FD ↗ |
| Apr 9, 2026 | Other events ↗ |
| Feb 20, 2026 | Results ↗ |
| Jan 29, 2026 | Director or officer change · Shareholder vote ↗ |
| Jan 28, 2026 | Results ↗ |